Sign In
Buy CLOV
$4.27
-0.0600 (-1.39%)
At Close: Aug 04, 2026
Clover Health: Clinical Excellence To Fuel SaaS Growth Beyond The Star Downgrade
07:30am, Wednesday, 29'th Oct 2025
Clover's latest star rating downgrade was mainly driven by low member experience scores, which is an aspect it fully controls in its business. Despite low member experience scores, members' ratings fo
Clover Health Investments (CLOV) Upgraded to Buy: Here's What You Should Know
01:01pm, Thursday, 23'rd Oct 2025
Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
04:30pm, Wednesday, 22'nd Oct 2025
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial O
Financial Review: P3 Health Partners (NASDAQ:PIII) vs. Clover Health Investments (NASDAQ:CLOV)
01:30am, Monday, 20'th Oct 2025
P3 Health Partners (NASDAQ: PIII - Get Free Report) and Clover Health Investments (NASDAQ: CLOV - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare
Clover Health's 2026 Medicare Advantage Plans Champion Affordability and Choice
08:30am, Wednesday, 15'th Oct 2025
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value The Company Reinforces Market Position, Maintaining Comprehensive PPO Portf
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
08:30am, Tuesday, 14'th Oct 2025
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
04:55pm, Thursday, 09'th Oct 2025
Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability1 through 2027, independent
Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025
08:30am, Tuesday, 07'th Oct 2025
WILMINGTON, Del., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated t
New VP Blaine Lindsey to Drive National Enterprise Growth; Gulf Region President Shannon Jacobs to Scale Operations in High-Need Markets New VP Blaine Lindsey to Drive National Enterprise Growth; Gulf
Counterpart Assistant Gets Conversational
08:30am, Thursday, 25'th Sep 2025
SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clove
Is Clover Health Investments (CLOV) Outperforming Other Medical Stocks This Year?
10:41am, Wednesday, 24'th Sep 2025
Here is how Clover Health Investments, Corp. (CLOV) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
Fast-paced Momentum Stock Clover Health Investments (CLOV) Is Still Trading at a Bargain
09:51am, Tuesday, 23'rd Sep 2025
Clover Health Investments (CLOV) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently bu
Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three decades Dr. Duncan's appointment to this p
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
08:30am, Tuesday, 16'th Sep 2025
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements Clover Health Continues to Invest in Streamlinin
WASHINGTON, D.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) – Clover Health CEO Andrew Toy today had
